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Recently, cardiac resynchronization therapy (CRT) has been established as an eﬀective
treatment for drug-resistant heart failure with left ventricular dyssynchrony in patients with a
New York Heart Association class (NYHA) of III-IV. Many cases have already been treated
with CRT in Japan, however, some challenges still remains, such as diﬃcult placement of the
left ventricular (LV) lead at the target site, high threshold values even after successful
placement of the LV lead, and the need to reposition of the LV lead due to diaphragmatic
stimulation regardless of an appropriate threshold value. In particular, those cases with high
threshold values at a distal site or those in which the lead is placed at a proximal site because
of diaphragmatic stimulation are prone to lead dislodgement, and re-operation may be
required. We report on a patient in whom stabilization of the LV lead was obtained by placing
a coronary stent in the coronary sinus wall which resulted in an improved clinical course.
(J Arrhythmia 2008; 24: 162–165)
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Introduction
In recent years cardiac resynchronization therapy
(CRT) has been used successful to decrease the
mortality and morbidity in heart failure patients with
cardiac dyssynchrony.1,2) At present, the most widely
used method for left ventricular (LV) lead placement
involves a transvenous LV lead placement via the
coronary sinus (CS) into a tributary branch. Lead
dislodgement is a common cause for a re-operation,
and continues to be a frequently experienced prob-
lem despite advances in the equipment and operator
techniques.
Case report
The patient was a 63-year-old male who under-
went repeated treatments for dilated cardiomyopathy
over several years. He developed drug-refractory
non-sustained ventricular tachycardia accompanied
by hemodynamic aggravation in 2003 and underwent
implantation of an implantable cardioverter deﬁb-
rillator (ICD). He became dependent on right
ventricular pacing, and his cardiac function gradual-
ly worsened in the presence of -blockers and
amiodarone. He developed heart failure and became
resistant to medical treatment in early 2007. Since
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echocardiography detected apparent left ventricular
dyssynchrony, he was admitted for surgery to
exchange his ICD with a cardiac resynchronization
therapy deﬁbrillator (CTR-D), and the operation was
performed in June 2007.
As shown in Figure 1, contrast imaging via a
guiding catheter inserted into the main vessel of the
CS, namely the great cardiac vein, suggested the
lateral and posterolateral branches were good candi-
dates for placement of the LV lead. We chose the
lateral branch ﬁrst because the systolic time intervals
were most delayed at this site as observed by
echocardiography. In this region the blood vessel
was relatively large so a 6-Fr. Attain OTW bipolar
lead (4194, Medtronic, Shoreview, MN, USA) was
selected. The stent was advanced into a distal site
where the threshold value of the LV lead was 2.2V
at a 0.5ms pulse width. However, diaphragmatic
stimulation was induced and that site was aban-
doned. We attempted to adjust the position 1–2 cm
proximally and distally, but placement was not
possible due to a worsened threshold value or
diaphragmatic stimulation. At a more proximal
position, the LV lead threshold was 2.5 V at a
0.5ms pulse width, indicating it was a good site for
placement. No diaphragmatic stimulation was in-
duced even at maximum stimulation. However, the
lead fell out into the main vessel after several
minutes, and that site also had to be abandoned.
Since the posterolateral branch was mildly curved,
and its distal threshold value was not adequate, the
lead was ﬁnally placed at a slightly proximal site
of the posterolateral branch in order to ﬁnish the
operation (Figure 2).
Four days later, the monitored stimulation wave-
form suddenly changed and the threshold was re-
evaluated and we found that pacing failure occurred
in the LV. A chest X-ray revealed an apparent
dislodgement of the LV lead. We suggested an
epicardial pacing lead placement to the patient but
he refused, and a re-operation for transvenous lead
placement procedure was performed on the follow-
ing day. We obtained the patient’s written informed
consent before the procedure stating that a stent
could be used to stabilize the lead in the CS if an
appropriate lead placement became impossible. The
in-hospital medical ethics committee approved this
trial. As the echocardiograpy just after the ﬁrst
operation revealed that the dyssynchrony had not
suﬃciently resolved with the lead placement in the
posterolateral branch, in this procedure a lateral
branch with the largest lag time was selected for
placement. A4-Fr. Attain OTW unipolar lead
(4193, Medtronic, Shoreview, MN, USA) was used
to place the lead at a more distal site, which was
achieved, but diaphragmatic stimulation occurred
again. Several centimeters along that site were
assessed. However, all sites were deemed inappro-
priate for placement because of either a bad
stimulation threshold value or the induction of
diaphragmatic stimulation. Therefore, we drew the
lead back to a more proximal site and assessed the
stimulation threshold and presence of diaphragmatic
stimulation. The LV stimulation threshold was good
at 1.8V with a 0.5ms pulse width, and no diaphrag-
matic stimulation was detected at maximum voltage.
We could not position the lead at the site since it
dropped into the main vessel after several minutes.
This prompted us to stabilize the lead by means
of a 2:0 20mm MicroDriver coronary stent
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Figure 1 Coronary venography is shown.
On contrast imaging via a guiding catheter inserted into the main vessel of the coronary sinus (great cardiac vein),
2 branches, the lateral and posterolateral, were visualized. (Panel A: RAO view, Panel B: LAO view)
Fujii S Stent placement in the coronary sinus
163
(Medtronic, Shoreview, MN, USA) which was
dilated, at a site about 3 cm proximal to the tip
electrode of the lead, at 8 atmospheres. The lead was
aﬃxed to the CS wall as shown in Figure 3.
No lead dislodgement, threshold elevation or
diaphragmatic stimulation has been observed 6
months after the operation. The patient’s subjective
symptoms have been abated, and a chest X-ray
revealed an reduction in the cardio-thoracic ratio
from 62% to 53% and echocardiography found
improvement of LV dyssynchrony.
Discussion
Although recent improvements in the shape and
material of LV leads have made delivery easier than
before, the problem of diaphragmatic stimulation
still remains and lead dislodgement occurs in 6–14
percent of all cases.3–5) We often encounter the
following dilemma: the lead is placed at the target
site and a good threshold value is obtained but
diaphragmatic stimulation forces us to abandon the
site. Even when diaphragmatic stimulation can be
resolved by adjusting the position from a middle to
more proximal site, lead dislodgement into the main
vessel may occur as in this case. Considering that the
prognosis in many patients indicated for CRT-D is
very poor without it, lead placement failures must be
avoided by all means. A high probability of lead
dislodgement would have been predicted for the
second operation if a coronary stent had not been
used for the lead stabilization. Epicardial lead
placement would be another option that could have
been considered in this patient, but our patient
refused it because he thought it would be too
invasive to tolerate. Although the previous failed
procedure and disadvantages of this new method
were explained to him, the patient gave us his prior
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Figure 2 The lateral branch was selected as the ﬁrst choice.
A6 Fr. Attain OTW bipolar lead (4194, Medtronic, Shoreview, MN, USA) was selected, and advanced to the peripheral site. The
threshold value of the left ventricular lead at this site was acceptable but diaphragmatic stimulation was induced and therefore this
site could not be used. (Panel A&B, A: RAO view, B: LAO view) The posterolateral branch was selected as a substitute. Since
the posterolateral branch was mildly curved, and the peripheral threshold value was not suﬃcient, the lead was ﬁnally placed at a
slightly proximal site in this branch. (Panel C&D, C: RAO view, D: LAO view)
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written informed consent after the in-hospital med-
ical ethics committee had approved this trial proce-
dure.
Main disadvantages of lead stabilization using a
coronary stent are lead damage, coronary venous
obstruction by thrombosis, and inability of re-
positioning or extraction.
Of the above disadvantages, lead damage can be
prevented by avoiding the use of a coronary stent
which is far bigger than the vascular diameter or
applying an excess pressure load in diastole. This
patient has been free from any abnormal lead
impedances or pacing failure after 6 months of
follow-up. Regarding coronary venous obstruction, it
would be unlikely for myocardial necrosis to occur
because the coronary venous blood circulates mu-
tually at the distal anastomosis site, even when the
coronary venous ﬂow becomes obstructed at the
stent placement site. The biggest challenge would be
a combination of re-positioning of the lead and it’s
extraction which is likely to occur and diﬃcult
to prevent when this stent method is used. The
possibility of successfully extracting a stented lead is
still unknown. At present, the long term-stability
and safety of this method is also unclear.
To the extent of our knowledge, there is only one
case report that presented the utilization of a
coronary stent to stabilize the lead in the CS.6) In
this report, the same problem was pointed out and
remained an unresolved problem. Future develop-
ment of leads which can be stabilized directly to the
blood vessel is greatly anticipated.
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Figure 3
Another 0.14-inch guide wire was passed adjacent to the
lead (Panel A), and a 2.0 x 20 mm MicroDriver coronary
stent (Medtronic, Shoreview, MN, USA) was dilated at
8 atmospheres at a site about 3 cm proximal to the lead
electrode tip. The lead was aﬃxed to the CS wall
(Panel B). Here the stent is not visible due to its
radiolucency; stent position is indicated with triangles
(Panel C).
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